릴게임바다이야기 ㉶ 69.reg198.top ㉶ 릴게임 온라인 씨엔조이
페이지 정보
작성자 교혜오외 작성일25-09-14 18:20 조회8회 댓글0건관련링크
-
http://49.rnf665.top
2회 연결
-
http://77.rqc718.top
1회 연결
본문
【62.reg198.top】
바다이야기 모바일 온라인백경 야마토연타 황금성3게임연타 바다이야기 조작 sp야마토 바다이야기노무현 황금성pc버전 야마토 창공 오션파라다이스 야마토2다운로드 오션파라다이스 릴게임 슬롯릴게임 무료충전야마토 야마토 릴게임 신천지 릴게임 공략법 야마토 빠칭코 사이다 릴게임 없습니다. 강원랜드 슬롯머신 규칙 오션파라다이스 예시 온라인야마토주소 종합릴게임 최신바다게임 슬롯게임 바다이야기 pc버전 릴게임추천사이트 게임황금성 릴게임 확률 슬롯모아 오리지날 야마토 오리지날황금성9게임 인터넷야마토게임 우주전함야마토2202 양귀비 릴게임 프라그마틱환수율 체리마스터게임 무료 충전 바다이야기 강원랜드 잭팟 확률 손오공게임 백경게임 하는곳주소 파친코게임 오션파라다이스 온라인 모바일릴게임 접속하기 알라딘릴 오션파라 다이스다운 파친코게임다운로드 바다시즌7게임 손오공게임다운로드 오션파라 다이스하는방법 바다이야기 파일 바다신2다운로드 프라그마틱 슬롯 체험 신천지 게임 창원경륜경륜장 무료슬롯머신777 무료 야마토 게임 바다이야기 pc버전 다운 골드몽먹튀 바다이야기게임사이트 황금성릴 온라인예시게임 pc릴게임 바다이야기환전가능 황금성포커게임 릴게임설치 파칭코사이트 프라그마틱 슬롯 무료 성인놀이터 카지노 슬롯머신 종류 황금성오락실게임 바다이야기 확률 카지노 슬롯머신 릴게임사이다 오션슬롯 바다이야기 슬롯머신 게임 슬롯 추천 디시 바다이야기기계가격 우주전함야마토먹튀 인터넷황금성 팡멀티릴게임 황금성 게임 릴게임용의눈 바다이야기먹튀 손오공 손오공릴게임예시 인터넷야마토게임 pc빠찡꼬게임 놀이터 릴박스 백경온라인 온라인백경게임 바다이야기2 인터넷 바다이야기 신천지게임하는곳 야마토오락 실게임 모바일릴게임종류 스위피릴게임 강원랜드게임종류 빠찡코 프라그마틱 슬롯 무료체험 무료바다이야기 파칭코 어플 바다이야기 먹튀 신고 야마토다운로드 황금성다운 성인오락게임 바다이야기 꽁머니 씨엔조이 릴게임 무료 야마토 게임 10원야마토게임 빠찡코 릴게임5만릴짱 바다게임이야기 바다이야기 릴게임 사이트 추천 및 안내 pc게임 바다게임사이트 황금성포커성 바다 슬롯 먹튀 바다이야기 2화 오션파라 다이스다운로드 오션파라 다이스다운로드 황금성 게임 장주소 릴114 [Shin-Min Joon, Edaily Reporter] Huons announced on the 8th that a real world clinical study on its fourth generation smart insulin pen, DIA:CONN P8, has been published in the September issue of the Diabetes & Metabolism Journal (DMJ) the official journal of the Korean Diabetes Association.
Professor Jae Hyeon Kim, Samsung Medical Center (Left) and Pr 신입생 국가장학금 ofessor So Yoon Kwon, Daegu Catholic University Medical Center (Right). (Image=Huons)
DMJ is an international journal indexed in the Science Citation Index 무담보무보증 Expanded (SCIE). The published article is titled “Effectiveness of the Stage 4 Smart Insulin Pen DIA:CONN P8 for Glycemic Control in a Real World Setting.”
The study was led by P 사용중이신 rofessor Soyoon Kwon and diabetes nurse educator Hyosun Kwak from the Department of Endocrinology and Metabolism at Daegu Catholic University Hospital, along with Professor Jaehyun Kim from the Depart 국민은행 적격대출 금리 ment of Endocrinology at Samsung Medical Center.
The research team analyzed the effectiveness of the smart insulin pen compared to conventional insulin pens in 42 adult diabetes patients (in 대학원생 대출 cluding both type 1 and type 2) who were on Multiple Daily Injections (MDI). All patients received Diabetes Self Management Education (DSME) and were then divided into two groups 21 using conventional insulin pens and 21 using the smart pen. Their blood glucose metrics were monitored over a two-week period using Continuous Glucose Monitoring (CGM).
The results showed that the smart pen group had 11.0% more time in range (70~180 mg/dL) compared to the conventional pen group. Time spent in hypoglycemia (TBR <70 mg/dL) was 2.6% lower and time in severe hypoglycemia (TBR <54 mg/dL) was reduced by 9%.
The Glycemic Risk Index (GRI) which comprehensively evaluates the risks of hyperglycemia and hypoglycemia, was also 18.2 points lower in the smart pen group.
According to the paper the average education time for the smart pen group was 3.4 hours, shorter than the 4.2 hours for the conventional pen group.
Nevertheless the smart pen group showed better glycemic control. This result contrasts with concerns from some users that smart insulin pens might be more difficult to use.
Professor Soyoon Kwon explained “The glucose lowering effect of the smart insulin pen is thanks to its automatic bolus (post meal insulin) calculation and the ability to track residual insulin in the body when used in conjunction with CGM. Patients can administer insulin precisely without complex calculations and avoid duplicate dosing, which helps reduce the risk of hypoglycemia.”
Professor Jaehyun Kim stated “This study is the first in Korea to demonstrate the glycemic benefits of smart insulin pens. Compared to costly insulin pumps smart pens offer a more affordable option while still providing patients with pump level glucose management benefits.”
DIA:CONN P8 is Korea’s first fourth generation smart insulin pen for diabetes and glucose management. It connects with CGMs like Dexcom G7 and integrates with the DIA:CONN diabetes management platform allowing users to view real time data on recent glucose levels and active insulin status.
It also automatically calculates post meal insulin (bolus) requirements to help prevent hypoglycemia. Huons launched the DIA:CONN P8 in 2023 under an exclusive domestic partnership with G2E.
신민준 (adonis@edaily.co.kr)
릴게임바다이야기 ㉶ 81.reg198.top ㉶ 릴게임 온라인 씨엔조이
릴게임바다이야기 ㉶ 49.reg198.top ㉶ 릴게임 온라인 씨엔조이
릴게임바다이야기 ㉶ 74.reg198.top ㉶ 릴게임 온라인 씨엔조이
릴게임바다이야기 ㉶ 9.reg198.top ㉶ 릴게임 온라인 씨엔조이
바다이야기 모바일 온라인백경 야마토연타 황금성3게임연타 바다이야기 조작 sp야마토 바다이야기노무현 황금성pc버전 야마토 창공 오션파라다이스 야마토2다운로드 오션파라다이스 릴게임 슬롯릴게임 무료충전야마토 야마토 릴게임 신천지 릴게임 공략법 야마토 빠칭코 사이다 릴게임 없습니다. 강원랜드 슬롯머신 규칙 오션파라다이스 예시 온라인야마토주소 종합릴게임 최신바다게임 슬롯게임 바다이야기 pc버전 릴게임추천사이트 게임황금성 릴게임 확률 슬롯모아 오리지날 야마토 오리지날황금성9게임 인터넷야마토게임 우주전함야마토2202 양귀비 릴게임 프라그마틱환수율 체리마스터게임 무료 충전 바다이야기 강원랜드 잭팟 확률 손오공게임 백경게임 하는곳주소 파친코게임 오션파라다이스 온라인 모바일릴게임 접속하기 알라딘릴 오션파라 다이스다운 파친코게임다운로드 바다시즌7게임 손오공게임다운로드 오션파라 다이스하는방법 바다이야기 파일 바다신2다운로드 프라그마틱 슬롯 체험 신천지 게임 창원경륜경륜장 무료슬롯머신777 무료 야마토 게임 바다이야기 pc버전 다운 골드몽먹튀 바다이야기게임사이트 황금성릴 온라인예시게임 pc릴게임 바다이야기환전가능 황금성포커게임 릴게임설치 파칭코사이트 프라그마틱 슬롯 무료 성인놀이터 카지노 슬롯머신 종류 황금성오락실게임 바다이야기 확률 카지노 슬롯머신 릴게임사이다 오션슬롯 바다이야기 슬롯머신 게임 슬롯 추천 디시 바다이야기기계가격 우주전함야마토먹튀 인터넷황금성 팡멀티릴게임 황금성 게임 릴게임용의눈 바다이야기먹튀 손오공 손오공릴게임예시 인터넷야마토게임 pc빠찡꼬게임 놀이터 릴박스 백경온라인 온라인백경게임 바다이야기2 인터넷 바다이야기 신천지게임하는곳 야마토오락 실게임 모바일릴게임종류 스위피릴게임 강원랜드게임종류 빠찡코 프라그마틱 슬롯 무료체험 무료바다이야기 파칭코 어플 바다이야기 먹튀 신고 야마토다운로드 황금성다운 성인오락게임 바다이야기 꽁머니 씨엔조이 릴게임 무료 야마토 게임 10원야마토게임 빠찡코 릴게임5만릴짱 바다게임이야기 바다이야기 릴게임 사이트 추천 및 안내 pc게임 바다게임사이트 황금성포커성 바다 슬롯 먹튀 바다이야기 2화 오션파라 다이스다운로드 오션파라 다이스다운로드 황금성 게임 장주소 릴114 [Shin-Min Joon, Edaily Reporter] Huons announced on the 8th that a real world clinical study on its fourth generation smart insulin pen, DIA:CONN P8, has been published in the September issue of the Diabetes & Metabolism Journal (DMJ) the official journal of the Korean Diabetes Association.
Professor Jae Hyeon Kim, Samsung Medical Center (Left) and Pr 신입생 국가장학금 ofessor So Yoon Kwon, Daegu Catholic University Medical Center (Right). (Image=Huons)
DMJ is an international journal indexed in the Science Citation Index 무담보무보증 Expanded (SCIE). The published article is titled “Effectiveness of the Stage 4 Smart Insulin Pen DIA:CONN P8 for Glycemic Control in a Real World Setting.”
The study was led by P 사용중이신 rofessor Soyoon Kwon and diabetes nurse educator Hyosun Kwak from the Department of Endocrinology and Metabolism at Daegu Catholic University Hospital, along with Professor Jaehyun Kim from the Depart 국민은행 적격대출 금리 ment of Endocrinology at Samsung Medical Center.
The research team analyzed the effectiveness of the smart insulin pen compared to conventional insulin pens in 42 adult diabetes patients (in 대학원생 대출 cluding both type 1 and type 2) who were on Multiple Daily Injections (MDI). All patients received Diabetes Self Management Education (DSME) and were then divided into two groups 21 using conventional insulin pens and 21 using the smart pen. Their blood glucose metrics were monitored over a two-week period using Continuous Glucose Monitoring (CGM).
The results showed that the smart pen group had 11.0% more time in range (70~180 mg/dL) compared to the conventional pen group. Time spent in hypoglycemia (TBR <70 mg/dL) was 2.6% lower and time in severe hypoglycemia (TBR <54 mg/dL) was reduced by 9%.
The Glycemic Risk Index (GRI) which comprehensively evaluates the risks of hyperglycemia and hypoglycemia, was also 18.2 points lower in the smart pen group.
According to the paper the average education time for the smart pen group was 3.4 hours, shorter than the 4.2 hours for the conventional pen group.
Nevertheless the smart pen group showed better glycemic control. This result contrasts with concerns from some users that smart insulin pens might be more difficult to use.
Professor Soyoon Kwon explained “The glucose lowering effect of the smart insulin pen is thanks to its automatic bolus (post meal insulin) calculation and the ability to track residual insulin in the body when used in conjunction with CGM. Patients can administer insulin precisely without complex calculations and avoid duplicate dosing, which helps reduce the risk of hypoglycemia.”
Professor Jaehyun Kim stated “This study is the first in Korea to demonstrate the glycemic benefits of smart insulin pens. Compared to costly insulin pumps smart pens offer a more affordable option while still providing patients with pump level glucose management benefits.”
DIA:CONN P8 is Korea’s first fourth generation smart insulin pen for diabetes and glucose management. It connects with CGMs like Dexcom G7 and integrates with the DIA:CONN diabetes management platform allowing users to view real time data on recent glucose levels and active insulin status.
It also automatically calculates post meal insulin (bolus) requirements to help prevent hypoglycemia. Huons launched the DIA:CONN P8 in 2023 under an exclusive domestic partnership with G2E.
신민준 (adonis@edaily.co.kr)
댓글목록
등록된 댓글이 없습니다.
